Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004150-17Phase 2Completed
Phase 2 trial of octreotide in Malnutrition, sponsored by Region Västra Götaland. Primary endpoint: Ad libitum calorie intake. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004150-17.